Clorox (CLX) Cost of Revenue (2009 - 2026)

Clorox's Cost of Revenue history runs 18 years deep, the most recent figure standing at $948.0 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 2.6% year-over-year to $948.0 million in Q1 2026; TTM through Mar 2026 was $3.8 billion, a 1.3% decrease from a year earlier, with the FY2025 full-year figure at $3.9 billion, down 3.81% from the prior year.
• Cost of Revenue steadied at $948.0 million in Q1 2026 per CLX's latest filing, from $951.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $1.2 billion in Q1 2022 and bottomed at $833.0 million in Q3 2025.
• The 5-year median for Cost of Revenue is $1.0 billion (2024), against an average of $1.0 billion.
• Across the five-year window, Cost of Revenue gained 15.19% in 2022 and fell 23.34% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $1.1 billion in 2022, then increased by 2.65% to $1.1 billion in 2023, then fell by 15.66% to $948.0 million in 2024, then grew by 0.32% to $951.0 million in 2025, then decreased by 0.32% to $948.0 million in 2026.
• Per Business Quant, the three latest CLX Cost of Revenue figures stand at $948.0 million (Q1 2026), $951.0 million (Q4 2025), and $833.0 million (Q3 2025).